Refresh

Piramal Pharma Ltd. - Research Center

543635 PPLPHARMA Group (A) BSE data
Back to Company

Results

Statement

More

Cash Flow
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21

Profit before tax

130.65 436.70 668.55

Net cashflow-operating activity

71.52 255.20 34.72

Net cash used in investing activity

-435.05 -1,223.02 -4,382.89

Netcash used in fin. activity

290.12 905.74 4,494.16

Net inc/dec in cash and equivlnt

-73.41 -62.08 145.99

Cash and equivalnt begin of year

127.69 146.73 0.74

Cash and equivalnt end of year

54.28 84.65 146.73
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com